Podcasts about chemistry nobel prize

Artificial Intelligence (AI) has changed dramatically in recent years. Today, AI is improving many industries and changing how we live. AI is now a key part of our future, making our lives easier and more efficient. But what is it that we need to look out for? What are some necessary measures to be taken to ensure a smooth and safe adoption of this technology? Watch this episode to learn about the past, present and future of AI. Your host, Mukesh Bansal, not only takes us through the journey of AI but also advices on how to navigate through this technological era. Resource List - More about Physics Nobel Prize - https://www.nobelprize.org/prizes/physics/2024/press-release/ More about Chemistry Nobel Prize - https://www.nobelprize.org/prizes/chemistry/2024/press-release/ More on Research behind Chemistry Nobel Prize Winners - https://youtu.be/KMfgV2QSlns?feature=shared Video by Deepmind on AlphaFold Server Demo - https://youtu.be/9ufplEgtq8w?feature=shared More on the first AI conference - https://home.dartmouth.edu/about/artificial-intelligence-ai-coined-dartmouth Watch the Chess Match between IBM Deep Blue v/s Garry Kasparov - https://youtu.be/KF6sLCeBj0s?feature=shared Watch IBM Watson on Jeopardy! - https://youtu.be/lI-M7O_bRNg?feature=shared 3Blue1Brown YouTube Channel - https://www.youtube.com/@3blue1brown Books from the episode: Perceptrons by Minsky - https://amzn.in/d/c8xn3Fh Genius Makers by Cade Metz - https://amzn.in/d/3pbTV1R The Master Algorithm by Pedro Domingos - https://amzn.in/d/14AiL3F Super Intelligence by Nick Bostrom - https://amzn.in/d/9hhq4td The Worlds I See by Dr. Fei-Fei Li - https://amzn.in/d/0iaga3Y Why Machines Learn by Anil Ananthaswamy - https://amzn.in/d/iiYC45X

This week we talk to Charles Harris, PhD student at The University of Cambridge who is looking at marrying the lessons learnt by 2024 Chemistry Nobel Prize winners and their game-changing AI tool for predicting protein structures called AlphaFold with generative modelling and drug discovery.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.This week's commercialization news includes updates on Zepbound supply, Enjaymo's new home, and expanding access to HIV drugs. Medicare has tweaked rules for drug price talks, while GSK reports that its RSV vaccine protects against disease over three seasons. GSK's Viiv plans to expand the supply of HIV drugs in Africa, and Sanofi's rare disease drug finds a new home at Recordati. Other news includes a protein prediction winning the Chemistry Nobel and Alnylam submitting an important drug application. Trends suggest that biosimilars may make a mark in 2025, with incentives favoring them in the Medicare market. Protein prediction wins the Chemistry Nobel Prize, Alnylam submits a crucial drug application, Lilly partners with AI specialist Insitro to develop metabolic medicines, and Purespring raises $105 million for gene therapy for kidney disease. AI startup Basecamp allies with The Broad Institute to create 'programmable' genetic medicines. Additionally, Lilly appoints Mount Sinai scientist Thomas Fuchs as its first Chief AI Officer to lead AI initiatives in drug discovery and clinical trials. Other news includes J&J closing a cancer study, Alnylam seeking approval for a potential blockbuster drug, and Propharma receiving a regulatory and compliance award at CPhI.The Supreme Court declined to review a Texas abortion case related to emergency care, a blow to the Biden administration's efforts. A survey found that nearly 70% of healthcare organizations affected by cyberattacks experienced disruptions in patient care. Steward Health Care is auctioning off assets, including closing Norwood Hospital in Massachusetts. Baxter reported no structural damage at their North Carolina site affected by Hurricane Helene. The payer-provider relationship in healthcare is becoming more complex with consolidation and value-based care, leading to tensions over reimbursement and access.Kezar's lupus trial has been put on hold after four patient deaths, making it a potential buyout target. Investor Kevin Tang is interested in acquisition. Big pharma is also investing in cell and gene therapies, with companies like Lilly and Sanofi making moves in the industry. The Genscript Biotech Global Forum 2025 is coming up on January 15, offering a platform to discuss innovations and challenges in gene and cell therapy. Additionally, Lilly's obesity clinical program faces challenges, while Stealth's ultrarare disease candidate may not meet approval standards.Eli Lilly's obesity program is highlighted as a key factor in the company's dominance in the industry, with CEO David Ricks confident in their position. Wuxi Biologics faces uncertainty in the U.S. after setbacks, while big pharma companies show growing interest in cell and gene therapy. Five radiopharma biotechs are identified as potential buyout targets, and Trilink Biotechnologies introduces custom sets of mRNA for screening studies. Other news includes increased investment in cell and gene therapy, activist investor Starboard's stake in Pfizer, and Merck's success with Keytruda in head and neck cancer. AstraZeneca puts $2 billion towards heart disease drugs, Sanofi offloads a rare autoimmune drug, and AbbVie trims earnings guidance.

THIS EPISODE OF GROWING OLDER LIVING YOUNGER highlights a unique carbon nano molecule, a C60 fullerene, that potentially may enhance longevity and promote healthy aging.  This carbon molecule was so significant that the discovery earned three scientists the 1996 Nobel Prize in Chemistry. Now it appears that it might play a major role in protecting key antioxidants in the body. Today's Featured Expert is scientist and entrepreneur, Chris Burres. Chris has an extensive background in a diverse range of areas including Mechanical Engineering,  Oil and Gas Explosives, Comedy Improv Artist, and Competitive Soccer. In 1991 he founded the first company to deliver carbon nano materials and two years later, he earned his B.S. in Mechanical Engineering from the University of Houston.Chris is the co-founder of MyVitalC  company. When he realized that one of the chemicals he sold, ESS60, the subject of the aforementioned Chemistry Nobel Prize, had been shown to significantly increase the lifespan of mammals, he struggled with the moral implications of marketing ESS60, as a supplement. So today's conversation will hopefully range from carbon chemistry, carbon nano materials specifically fullerenes, to the potential human benefits of these antioxidants and ethics of supplement marketing. Episode Timeline3:12  Intro to today's episode 4:52 The discovery of fullerenes in 1985. 2:42 Nanotechnology vs. carbon nanotechnology. 17:32The single longest longevity experiment 21:54 Problems with longevity studies in humans.  27:19 The inaugural change your aging program. ) 31:05 Understanding the quality of supplements? 36:47  Mitochondrial energy support by Vitality supplement. Learn more about Chris Burres and ESS60  www.myvitalc.com/drgil use coupon: drgill Meet Dr. Gillian Lockitch Change Your Aging Masterplan:  Reversing Aging to Live Younger Longer  For more information book a  free Discovery Call with me. To get your copy of Growing Older Living Younger: The Science of Aging Gracefully and The Art of Retiring Comfortably click here  Email  Dr. Gill at askdrgill@gmail.com And if you have not already done so, follow,  rate and review the show. 

1921 Chemistry Nobel Prize - Frederick Soddy. Broadcast on OAR 105.4FM Dunedin www.oar.org.nz

Daniel Griffin provides a clinical report on COVID-19, then Amy joins us to discuss the 2020 Chemistry Nobel Prize for gene editing using CRISPR/Cas9, continuing circulation of poliovirus in Afghanistan, inborn errors of interferon in patients with severe COVID-19, and listener questions. Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Guests: Daniel Griffin and Amy Rosenfeld Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode ASH guidelines on anticoagulants in COVID-19 patients (ASH) Followup of adults with noncritical COVID-19 (Clin Micr Inf) Tocilizumab in COVID-19 ICU patients (Lancet Rheum) Biological safety officer position at CUMC Support MicrobeTV at Parasites Without Borders 2020 Nobel Prize Chemistry (pdf) Progress towards polio eradication Afghanistan (MMWR) Inborn errors of IFN and serious COVID-19 (Science) Letters read on TWiV 671 Timestamps by Jolene. Thanks! Weekly Science Picks Amy - Coronavirus : A book for children by Kate Wilson and Nia Roberts Alan - Lost Prologue Rich -RAPS COVID-19 vaccine tracker Vincent - A Crack in Creation by Doudna and Sternberg and Sternberg on TWiM 184 Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Daniel Griffin provides a clinical report on COVID-19, then Amy joins us to discuss the 2020 Chemistry Nobel Prize for gene editing using CRISPR/Cas9, continuing circulation of poliovirus in Afghanistan, inborn errors of interferon in patients with severe COVID-19, and listener questions. Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Guests: Daniel Griffin and Amy Rosenfeld Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode ASH guidelines on anticoagulants in COVID-19 patients (ASH) Followup of adults with noncritical COVID-19 (Clin Micr Inf) Tocilizumab in COVID-19 ICU patients (Lancet Rheum) Tech position with Dr. Rosenfeld Biological safety officer position at CUMC Support MicrobeTV at Parasites Without Borders 2020 Nobel Prize Chemistry (pdf) Progress towards polio eradication Afghanistan (MMWR) Inborn errors of IFN and serious COVID-19 (Science) Letters read on TWiV 671 Timestamps by Jolene. Thanks! Weekly Science Picks Amy - Coronavirus : A book for children by Kate Wilson and Nia Roberts Alan - Lost Prologue Rich -RAPS COVID-19 vaccine tracker Vincent - A Crack in Creation by Doudna and Sternberg and Sternberg on TWiM 184 Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Kizzmekia Corbett joins TWiV to review her career and her work on respiratory syncytial virus, influenza virus, and coronaviruses and coronavirus vaccines, including her role in development and testing of a spike-encoding mRNA vaccine, and then we review the Nobel Prize for discovery of hepatitis C virus. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler and Brianne Barker Guest: Kizzmekia Corbett Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Pre-fusion structure of CoV spike (Nature) Pre-fusion structure of SARS-CoV-2 spike (Science) Evaluation of mRNA-1273 in nonhuman primates (NEJM) SARS-CoV-2 vaccine from pandemic preparedness (Nature) Nanoparticulate universal influenza vaccine from stem antigens (mBio) Biological safety officer position at Columbia U Medicine Nobel Prize for Hepatitis C virus (pdf) Alter's work on non-A non-B hepatitis (paper one, paper two) Houghton: single clone of HCV genome (Science) Rice: Transmission of hepatitis C to chimpanzee (Science) Charlie Rice on TWiV 392 Chemistry Nobel Prize to Doudna and Charpentier (Nobel.org) FDA releases stricter guidelines for COVID-19 vaccines (NY Times, FDA pdf) Bullet points of Das coronavirus Recovery of 1918 influenza virus stories (one, two) Letters read on TWiV 670 Timestamps by Jolene. Thanks! Weekly Science Picks Brianne - COVID-19 in Molecular Detail for Teaching Kathy – Mars shining brightest since 2003 Rich - Lost Prologue Vincent - Girl from Ipanema is weirder than you thought Listener Pick Sandra - Learn Medical Research Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Kizzmekia Corbett joins TWiV to review her career and her work on respiratory syncytial virus, influenza virus, and coronaviruses and coronavirus vaccines, including her role in development and testing of a spike-encoding mRNA vaccine, and then we review the Nobel Prize for discovery of hepatitis C virus. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler and Brianne Barker Guest: Kizzmekia Corbett Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Pre-fusion structure of CoV spike (Nature) Pre-fusion structure of SARS-CoV-2 spike (Science) Evaluation of mRNA-1273 in nonhuman primates (NEJM) SARS-CoV-2 vaccine from pandemic preparedness (Nature) Nanoparticulate universal influenza vaccine from stem antigens (mBio) Biological safety officer position at Columbia U Medicine Nobel Prize for Hepatitis C virus (pdf) Alter's work on non-A non-B hepatitis (paper one, paper two) Houghton: single clone of HCV genome (Science) Rice: Transmission of hepatitis C to chimpanzee (Science) Charlie Rice on TWiV 392 Chemistry Nobel Prize to Doudna and Charpentier (Nobel.org) FDA releases stricter guidelines for COVID-19 vaccines (NY Times, FDA pdf) Bullet points of Das coronavirus Recovery of 1918 influenza virus stories (one, two) Letters read on TWiV 670 Timestamps by Jolene. Thanks! Weekly Science Picks Brianne - COVID-19 in Molecular Detail for Teaching Kathy – Mars shining brightest since 2003 Rich - Lost Prologue Vincent - Girl from Ipanema is weirder than you thought Listener Pick Sandra - Learn Medical Research Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Walther Nernst, winner of the 1920 Nobel Prize for Chemistry. Broadcast on OAR 105.4FM Dunedin www.oar.org.nz

1915 Chemistry Nobel Prize - Richard Willstatter and Chlorophyll Broadcast on OAR 105.4FM Dunedin www.oar.org.nz

1913 Chemistry Nobel Prize winner - Dave talks about the 1913 Chemistry Nobel Prize winner Alfred Nobel Broadcast on OAR 105.4FM Dunedin www.oar.org.nz

John B. Goodenough, M. Stanley Whittingham and Akira Yoshino share the 2019 Nobel Prize in Chemistry “for the development of lithium-ion batteries” that have led to portable electronic devices that are rechargeable virtually anywhere on the planet.

In the final episode of Season 1, the boys finish their 3-part series on the Christopher Nolan Batman movies, and The Dark Knight Rises is easily the worst one! Steven tells us about neutron bombs and the difference between nuclear bombs and nuclear reactors; Scott tells us how much cooler Bain and Batman are in the books; we find that hanging from a rope does not, in fact, regenerate your cartilage. Steven tells us that microscopes are good enough to take pictures of single molecules and tells us 3 ways to do it, then tells us about the difference between nanoscience and molecular machines! 3 Chemistry Nobel Prize shout-outs in this episode! Contact us with questions, comments, and topic suggestions! Email: ScienceAndFictionPod@gmail.com IG/Twitter/Facebook: @SciAndFic Recorded March 2, 2019 Theme Music: Mobile Electro by Marc Torch (via Epidemic Sound)

In an astonishing story of a scientific discovery, Greg Winter tells Jim Al-Khalili how decades of curiosity-driven research led to a revolution in medicine. Forced to temporarily abandon his work in the lab when a road rage incident left him with a paralysed right arm, Greg Winter spent several months looking at the structure of proteins. Looking at the stunning computer graphics made the pain in his arm go away. It also led him to a Nobel Prize winning idea: to ‘humanise' mouse antibodies. A visit to an old lady in hospital made Greg determined to put his research to good use. He fought hard to ensure open access to the technology he invented and set up a start up company to encourage the development of therapeutic drugs. It took years to persuade anyone to fund his Nobel Prize winning idea that led to the creation of an entirely new class of drugs, known as monoclonal antibodies. In 2018, the market for these drugs, which include Humira for rheumatoid arthritis and Herceptin for breast cancer, was worth $70 billion. Producer: Anna Buckley

DIY genetic engineering, Potatoes stop bleeding, Gaffa tape stops warts, and Venusian bacteria by Ian Woolf 2002 Chemistry Nobel Prize - identifying biological macro-molecules by Chris Stewart, Absinthe science by Adam Mark, 2002 IgNobel Prizes - Scrotal asymmetry in man and ancient sculpture, beer froth obeys law of exponential decay, washing machine for cats and dogs, belly button lint by Chris Stewart Hosted by Adam Mark, Produced by Chris Stewart, Technical support by Gina Satore, re-edited by Ian Woolf. This show was originally broadcast in October 2002 Support Diffusion by making a contribution bitcoin: 1AEnJC8r9apyXb2N31P1ScYJZUhqkYWdU2 ether: 0x45d2cd591ff7865af248a09dc908aec261168395

The Nobel Prize in Chemistry was awarded today to Jean-Pierre Sauvage, Sir James Fraser Stoddart and Bernard L. Feringa for the design and synthesis of molecular machines.    

SynTalk thinks about the dynamic nature & origins (since the big bang) of fundamental & emergent forces in the universe. Was there only one force at the time of big bang? How did human beings first recognize & understand both the forces of nature (shamanism, magic, storms, lightning) and the forces more in their control (combat, weapons, hunting, push & pull)? The concepts are derived off / from Aristotle, Galileo, Laplace, Newton, Halley, Oersted, Faraday, Maxwell, Mach, Bohr, Planck, Einstein, Schrodinger, Heisenberg, Higgs, Max Jammer, & Karplus / Levitt / Warshel (2013 Chemistry Nobel Prize winners), among others. How is the world held together by the various forces? What exactly is a force field? Can there be force without matter (Yes)? Does matter create its field, or can a field be its own source? How to think of Maxwell’s equations in ‘free space’, and why we need matter (as sources for (say) microphones & radio)? How do forces act at a distance? Why do we try to create early universe conditions in large colliders, and study strong & weak forces? How did the forces separate (gravitation, electromagnetism, weak & strong forces, in that order) as the universe cooled down? Why don’t bodies simply move in a straight line, and links with the concept of ‘natural motion’? Is it (even) possible to know why forces exist? Is Big Bang the new ‘prima mobilia’, and how much more do we conceptually know about forces now? How do strongly interacting (uncertain) electrons / atoms get confined in a classical body, and links with concepts of multiscaling (QM/MM; Quantum Mechanics/Molecular Mechanics) and the mesoscopic world? Why an electrical circuit is difficult to understand in terms of electromagnetic field theory. How forces bind parts together and why / how a different whole sometimes emerges? How the degrees of freedom get frozen as the number of bodies increase. Why did Bohr’s premise of simply quantizing angular momentum did not work for many-electron atoms (beyond hydrogen-like atoms)? Link of the grey zone (‘interface region’) between quantum mechanics & classical mechanics with drugs, proteins, buildings, brain, cricket ball, polymers, spark plug, steering wheel, effective theory, & wave-particle duality. How does a magnet defeat the earth and pull a piece of iron, and its links with gauge theory (with all three forces, except gravity) and the possibility of gravity as an entropic or emergent force? Are market, political, or life forces similar entropic forces? Why is gravity difficult to unify with the other forces? Has ‘force’ replaced ‘energy’ since mid 19th century (after the energy-ists)? Are a different set of forces likely to govern dark matter and dark energy? Is force just a defined concept and not purely fundamental? The SynTalkrs are: Prof. S. D. Agashe (electrical engineering, history & philosophy of science, IITB, Mumbai), Dr. Sourav Pal (quantum chemistry, NCL, Pune), Prof. Sreerup Raychaudhuri (particle physics, TIFR, Mumbai).